PFA
ABBV icon

Pathway Financial Advisors’s AbbVie ABBV Stock Holding History

Pathway Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$991K Buy
3,797
+1,014
+36% +$218K 0.12% 68
2026
Q1 		$581K Sell
2,783
-299
-10% -$66.3K 0.07% 82
2025
Q4 		$690K Sell
3,082
-50
-2% -$11.4K 0.09% 77
2025
Q3 		$725K Hold
3,132
– – 0.1% 75
2025
Q2 		$581K Sell
3,132
-25
-0.8% -$4.65K 0.09% 80
2025
Q1 		$661K Sell
3,157
-25
-0.8% -$4.86K 0.12% 79
2024
Q4 		$565K Buy
3,182
+100
+3% +$18.4K 0.13% 82
2024
Q3 		$609K Hold
3,082
– – 0.16% 76
2024
Q2 		$529K Sell
3,082
-28
-0.9% -$4.64K 0.14% 82
2024
Q1 		$566K Buy
3,110
+110
+4% +$19K 0.15% 75
2023
Q4 		$465K Sell
3,000
-122
-4% -$17.8K 0.13% 88
2023
Q3 		$465K Buy
3,122
+122
+4% +$17.9K 0.16% 69
2023
Q2 		$404K Buy
3,000
+15
+0.5% +$2.2K 0.13% 77
2023
Q1 		$476K Buy
2,985
+145
+5% +$22.2K 0.16% 65
2022
Q4 		$459K Sell
2,840
-1,982
-41% -$304K 0.14% 68
2022
Q3 		$647K Buy
4,822
+900
+23% +$129K 0.22% 48
2022
Q2 		$601K Hold
3,922
– – 0.25% 50
2022
Q1 		$636K Sell
3,922
-65
-2% -$9.44K 0.24% 51
2021
Q4 		$546K Buy
+3,987
New +$471K 0.19% 58
2021
Q1 		$467K Hold
3,987
– – 0.18% 65
2020
Q4 		$430K Hold
3,987
– – 0.18% 61
2020
Q3 		$347K Sell
3,987
-19
-0.5% -$1.79K 0.13% 64
2020
Q2 		$393K Sell
4,006
-300
-7% -$26.4K 0.12% 55
2020
Q1 		$316K Hold
4,306
– – 0.11% 63
2019
Q4 		$379K Buy
4,306
+600
+16% +$49.8K 0.11% 72
2019
Q3 		$316K Sell
3,706
-31
-0.8% -$2.13K 0.09% 70
2019
Q2 		$272K Buy
3,737
+96
+3% +$7.55K 0.08% 79
2019
Q1 		$293K Buy
3,641
+19
+0.5% +$1.55K 0.09% 74
2018
Q4 		$334K Hold
3,622
– – 0.19% 64
2018
Q3 		$329K Hold
3,622
– – 0.18% 66
2018
Q2 		$336K Hold
3,622
– – 0.2% 58
2018
Q1 		$343K Sell
3,622
-16
-0.4% -$1.76K 0.2% 59
2017
Q4 		$352K Buy
+3,638
New +$343K 0.2% 57

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Pathway Financial Advisors's ABBV Position: Q2 2026 in Review

Pathway Financial Advisors increased its AbbVie (ABBV) stake by 36% in Q2 2026, buying an estimated $218K and bringing the position to 3,797 shares worth $991K. The position accounts for 0.12% of the portfolio, ranked #68.

Pathway Financial Advisors first reported a position in ABBV in Q4 2017 and has held it in 33 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pathway Financial Advisors held 3,797 shares of AbbVie worth $991K as of Q2 2026.
  • Pathway Financial Advisors bought 1,014 AbbVie shares in Q2 2026, an estimated $218K.
  • AbbVie made up 0.12% of Pathway Financial Advisors's portfolio in Q2 2026, its #68 holding.
  • Pathway Financial Advisors first reported a position in AbbVie in Q4 2017 and has held it in 33 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pathway Financial Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.